[Namespace]
Keyword=HBP
NameString=Human Brain Pharmacome Terminology
DomainString=Other
VersionString=20181119
CreatedDateTime=2018-11-19T10:27:58
DescriptionString=The Human Brain Pharmacome Terminology contains terms related to neurodegenerative disease and curation of related material. It is not disease-specific, but at leasthas a focus on Alzheimer's disease.

[Author]
NameString=Charles Tapley Hoyt
CopyrightString=CC0 1.0 Universal

[Citation]
NameString=HBP

[Processing]
CaseSensitiveFlag=yes
DelimiterString=|
CacheableFlag=yes

[Values]
2-Bromohexadecanoic acid|ABCGMOPR
2-O-sulfated heparin|ABCGMOPR
20 S Proteasome|ABCGMOPR
3-3 dityrosine cross-linking|ABCGMOPR
310-helix|ABCGMOPR
3R tau|ABCGMOPR
4R tau|ABCGMOPR
4R tauopathy|ABCGMOPR
6-O-sulfated heparin|ABCGMOPR
8-nitro-cGMP|ABCGMOPR
A2B5 antigen|ABCGMOPR
ACY-1215|ABCGMOPR
AG73|ABCGMOPR
AICD|ABCGMOPR
AP-2 complex|ABCGMOPR
APOE e3|ABCGMOPR
APOE e4|ABCGMOPR
APP C-terminally truncated carboxyl-terminal fragments|ABCGMOPR
APP processing|ABCGMOPR
APP, ACR|ABCGMOPR
APP695|ABCGMOPR
APP751|ABCGMOPR
APP770|ABCGMOPR
Abeta*56|ABCGMOPR
Alpha-synuclein Oligomerization|ABCGMOPR
Alz50|ABCGMOPR
Amylin Antagonist AC253|ABCGMOPR
Argyrophilic Grain Disease|ABCGMOPR
Astrogliosis|ABCGMOPR
AβOs|ABCGMOPR
BAY61-3606|ABCGMOPR
Bacterial invasion|ABCGMOPR
Biphenyl-4-yl-acrylohydroxamoc acids|ABCGMOPR
Braak_Stage I|ABCGMOPR
Braak_Stage II|ABCGMOPR
Braak_Stage III|ABCGMOPR
Braak_Stage IV|ABCGMOPR
Braak_Stage V|ABCGMOPR
Braak_Stage VI|ABCGMOPR
Brodmann (1909) area 36|ABCGMOPR
C-30-27|ABCGMOPR
C31|ABCGMOPR
C646|ABCGMOPR
C99|ABCGMOPR
CA1 field of hippocampus|ABCGMOPR
CA2 field of hippocampus|ABCGMOPR
CA3 field of hippocampus|ABCGMOPR
CA4 field of hippocampus|ABCGMOPR
CAG repeats|ABCGMOPR
CDK5R1 p25|ABCGMOPR
CGP3466B|ABCGMOPR
CK1 superfamily|ABCGMOPR
CLR01|ABCGMOPR
CM-414|ABCGMOPR
CRL4 complex|ABCGMOPR
CagA peptide|ABCGMOPR
Chronic cerebral hypoperfusion|ABCGMOPR
Corticobasal Degeneration|ABCGMOPR
D6S253|ABCGMOPR
D6S305|ABCGMOPR
DAPK, basic loop (BL) motif|ABCGMOPR
Dopaminergic cell groups|ABCGMOPR
E1 domain|ABCGMOPR
E2 domain|ABCGMOPR
ER mitochondria interorganellar crosstalk|ABCGMOPR
Excitotoxicity|ABCGMOPR
FMR1,(55-200 CGG)|ABCGMOPR
GA-AGE|ABCGMOPR
GAL80TS|ABCGMOPR
GDNF Family|ABCGMOPR
GRB10,BPS domain|ABCGMOPR
GVD bodies|ABCGMOPR
Gastrointestinal dysfunctions|ABCGMOPR
Glutamate excitotoxicity|ABCGMOPR
Histone H3|ABCGMOPR
Hyperamylinemia|ABCGMOPR
ID-8|ABCGMOPR
IκB kinase|ABCGMOPR
Jcasp|ABCGMOPR
KXGS motif|ABCGMOPR
Kalirin 7|ABCGMOPR
LDN-193594|ABCGMOPR
LDN-193665|ABCGMOPR
LDN-213843|ABCGMOPR
LMW amyloid oligomers|ABCGMOPR
LPLI|ABCGMOPR
LY293002|ABCGMOPR
Long-Term Depression|ABCGMOPR
MARK4 isoform 2 (688 aa)|ABCGMOPR
MLS000034832|ABCGMOPR
MPT0G211|ABCGMOPR
MTHFR,TT+AA|ABCGMOPR
Microgliosis|ABCGMOPR
Mitochondrial pathway|ABCGMOPR
Mori Fructus ethanol extract|ABCGMOPR
Motor Neurons|ABCGMOPR
Muscles|ABCGMOPR
N-AcGIP|ABCGMOPR
NP_001387.2:p.Arg205del|ABCGMOPR
NP_001387.2:p.Glu239del|ABCGMOPR
Neural Stem Cell|ABCGMOPR
Neurites|ABCGMOPR
Neurodegeneration|ABCGMOPR
Neuroglia|ABCGMOPR
Notch intracellular domain|ABCGMOPR
O-GlcNAcylation|ABCGMOPR
P3 peptide|ABCGMOPR
PARK7-alpha helices|ABCGMOPR
PDR-1|ABCGMOPR
PI3K-Akt signaling pathway|ABCGMOPR
PINK-1|ABCGMOPR
PINK1-Park pathway|ABCGMOPR
PTI-125|ABCGMOPR
Pars Compacta|ABCGMOPR
Pathological Tau Spreading|ABCGMOPR
PrP106-126|ABCGMOPR
PrPSc|ABCGMOPR
Pro3-GIP|ABCGMOPR
Purkinje cell layer of cerebellar cortex|ABCGMOPR
RAC1b|ABCGMOPR
RGFP966|ABCGMOPR
SEN-1269|ABCGMOPR
SL-327|ABCGMOPR
ST7612AA1|ABCGMOPR
Serpin-enzyme complex receptor|ABCGMOPR
Spinocerebellar Ataxia 11|ABCGMOPR
Syndecan Family|ABCGMOPR
TGM2 Isoform 3 (349 aa)|ABCGMOPR
TIM/TOM complex|ABCGMOPR
TOC1|ABCGMOPR
Tau C3|ABCGMOPR
Tau MN423|ABCGMOPR
Tau Protein Secondary Structure, Turn|ABCGMOPR
Tau aggregates|ABCGMOPR
Tau annular protofibrils|ABCGMOPR
Tau antibody|ABCGMOPR
Tau antibody, 40E8|ABCGMOPR
Tau antibody, 4E4|ABCGMOPR
Tau antibody, 6C5|ABCGMOPR
Tau antibody, AGG5759|ABCGMOPR
Tau antibody, HT7|ABCGMOPR
Tau antibody, RG7345|ABCGMOPR
Tau antibody, TNT1|ABCGMOPR
Tau antibody, TNT2|ABCGMOPR
Tau antibody, Tau-13|ABCGMOPR
Tau antibody, Tau46|ABCGMOPR
Tau antibody, pS396|ABCGMOPR
Tau dimers|ABCGMOPR
Tau epitope|ABCGMOPR
Tau epitope, 12E8|ABCGMOPR
Tau epitope, AD2|ABCGMOPR
Tau epitope, AP422|ABCGMOPR
Tau epitope, AT100|ABCGMOPR
Tau epitope, AT180|ABCGMOPR
Tau epitope, AT270|ABCGMOPR
Tau epitope, AT8|ABCGMOPR
Tau epitope, CP13|ABCGMOPR
Tau epitope, PHF1|ABCGMOPR
Tau fibrils|ABCGMOPR
Tau isoform A (316 aa)|ABCGMOPR
Tau isoform B (381 aa)|ABCGMOPR
Tau isoform C (410 aa)|ABCGMOPR
Tau isoform D (383 aa)|ABCGMOPR
Tau isoform E (412 aa)|ABCGMOPR
Tau isoform F (441 aa)|ABCGMOPR
Tau isoform Fetal-tau (352 aa)|ABCGMOPR
Tau oligomers|ABCGMOPR
Thiamet G|ABCGMOPR
Thioflavin S|ABCGMOPR
Trithiocarbonates|ABCGMOPR
Tubacin|ABCGMOPR
Tubastatin A|ABCGMOPR
USP14 Aptamer|ABCGMOPR
VQIINK motif|ABCGMOPR
VQIVYK motif|ABCGMOPR
VU0029767|ABCGMOPR
VU0090157|ABCGMOPR
VU0152099|ABCGMOPR
VU0184670|ABCGMOPR
VU0456940|ABCGMOPR
VU10010|ABCGMOPR
Ventral Tegmental Area|ABCGMOPR
YENPTY endocytosis motif (APP)|ABCGMOPR
aMCI|ABCGMOPR
abf-2|ABCGMOPR
advanced glycation end product|ABCGMOPR
alpha-3 beta-2 nAChR|ABCGMOPR
alpha-4 beta-2 nAChR|ABCGMOPR
alpha-4 beta-4 nAChR|ABCGMOPR
alpha-4-containing nAChR|ABCGMOPR
alpha-6-containing nAChR|ABCGMOPR
alpha-7 beta-2 nAChR|ABCGMOPR
alpha-7-containing nAChR|ABCGMOPR
alpha-Bungarotoxin|ABCGMOPR
alpha-synuclein aggregates|ABCGMOPR
alpha-synuclein fibrils|ABCGMOPR
alpha-synuclein oligomers|ABCGMOPR
alternative splicing of APP gene|ABCGMOPR
amyloid-beta 40 oligomers|ABCGMOPR
amyloid-beta 42 oligomers|ABCGMOPR
amyloid-beta aggregates|ABCGMOPR
amyloid-beta derived diffusible ligands|ABCGMOPR
amyloid-beta fibrils|ABCGMOPR
amyloid-beta oligomers|ABCGMOPR
amyloidogenesis|ABCGMOPR
assembly domain|ABCGMOPR
beta-2-containing nAChR|ABCGMOPR
caprospinol|ABCGMOPR
ced-9|ABCGMOPR
cerebral cortex|ABCGMOPR
cholinergic neuron|ABCGMOPR
cis p-tau|ABCGMOPR
cleaved PINK1|ABCGMOPR
clec-4|ABCGMOPR
clec-65|ABCGMOPR
common fragile site|ABCGMOPR
crebinostat|ABCGMOPR
cystein-dependent auto-acetylation|ABCGMOPR
dense core plaques|ABCGMOPR
detyrosination|ABCGMOPR
diaminothiazole|ABCGMOPR
dopamine homeostasis|ABCGMOPR
dystrophic neurite|ABCGMOPR
entorhinal cortex layer 2|ABCGMOPR
exotoxin A|ABCGMOPR
formylation|ABCGMOPR
gamma-secretase|ABCGMOPR
ghost tangles|ABCGMOPR
glycation|ABCGMOPR
granular layer of cerebellar cortex|ABCGMOPR
granular tau oligomers|ABCGMOPR
granulovacuolar degeneration|ABCGMOPR
growth factor|ABCGMOPR
heat shock proteins|ABCGMOPR
high-calorie diets|ABCGMOPR
hsp-16|ABCGMOPR
huntingtin aggregates|ABCGMOPR
hydrophobic pocket of actin|ABCGMOPR
hyperphosphorylation|ABCGMOPR
hyposmia|ABCGMOPR
indirubin|ABCGMOPR
isocarboxazide|ABCGMOPR
isopentanyladenine|ABCGMOPR
kappa-Bungarotoxin|ABCGMOPR
lgg-1|ABCGMOPR
long-term potentiation|ABCGMOPR
lys-2|ABCGMOPR
maitotoxin|ABCGMOPR
mdMCI|ABCGMOPR
mevalonate pathway|ABCGMOPR
microtubule-binding region|ABCGMOPR
midbrain dopaminergic neuron|ABCGMOPR
mitochondrial DAMPs|ABCGMOPR
mitochondrial aggregation|ABCGMOPR
mitochondrial dysfunction|ABCGMOPR
mitochondrial homeostasis|ABCGMOPR
mitochondrial motility|ABCGMOPR
mitochondrial precursor protein|ABCGMOPR
molecular layer of cerebellar cortex|ABCGMOPR
nasal cycle|ABCGMOPR
neurite retraction|ABCGMOPR
neuroinflammation|ABCGMOPR
neurotoxicity|ABCGMOPR
neurovascular unit|ABCGMOPR
neutral sphingomyelinase|ABCGMOPR
nitration|ABCGMOPR
non-shivering thermogenesis|ABCGMOPR
noradrenergic neuron|ABCGMOPR
olfactory epithelium|ABCGMOPR
olomoucine|ABCGMOPR
oxazolidinedione|ABCGMOPR
oxidative protein folding|ABCGMOPR
p83|ABCGMOPR
paired helical filaments|ABCGMOPR
peripheral nervous system injury|ABCGMOPR
phosphatase-activating domain|ABCGMOPR
pof14|ABCGMOPR
polyamination|ABCGMOPR
polysumoylation|ABCGMOPR
prefibrillar α-synuclein oligomers|ABCGMOPR
pretangles|ABCGMOPR
projection domain|ABCGMOPR
proline-rich domain|ABCGMOPR
proline-rich region 1|ABCGMOPR
proline-rich region 2|ABCGMOPR
protein aggregates|ABCGMOPR
proteotoxicity|ABCGMOPR
sAPP-alpha|ABCGMOPR
sAPP-beta|ABCGMOPR
sAPP-gamma|ABCGMOPR
skn-1|ABCGMOPR
sonicated tau fibrils|ABCGMOPR
ss20399075|ABCGMOPR
straight filaments|ABCGMOPR
sudoxicam|ABCGMOPR
thiohydantoin|ABCGMOPR
thioxooxazolidine|ABCGMOPR
tideglusib|ABCGMOPR
tubulin detyrosination|ABCGMOPR
tubulin-binding repeat 1|ABCGMOPR
tubulin-binding repeat 2|ABCGMOPR
tubulin-binding repeat 3|ABCGMOPR
tubulin-binding repeat 4|ABCGMOPR
tunneling nanotubes|ABCGMOPR